Researchers have developed a new family of chemicals that bind specifically to the gp41 pocket, halting HIV's ability to infect cells. The compounds, created using mirror-image phage display, show promise as potential oral treatments for HIV, with advantages including reduced cell membrane penetration and lower likelihood of resistance.
A $55 million grant from NIDA is supporting the development of new drug addiction treatments through collaboration between researchers and community treatment providers. Over five years, Oregon will receive $11 million to test promising science-based treatments in real-life settings.
A study found that tumor necrosis factor-alpha (TNF-alpha) plays a crucial role in early liver damage caused by alcohol consumption. The researchers used gene knockout technology to show that TNF-alpha mediates the development of liver injury, leading to potential new drug therapies for conditions affecting millions of Americans.
A Yale study suggests that breast cancer patients with BRCA1 or BRCA2 genes are at higher risk of late relapses after treatment. Women with these mutations respond well to initial therapy but may develop second tumors years later.
Researchers identified a class of compounds that prevent HIV from infecting cells by blocking the viral entry into the cell. The discovery holds great promise for identifying a new class of oral drugs for treating HIV infection and AIDS.
The discovery of 78 Neanderthal bones at Moula-Guercy suggests that European Neanderthals practiced cannibalism, systematically defleshing and breaking apart the bones to remove marrow and brains. The abundance of natural resources available at the site makes survival-based cannibalism unlikely.
Elevated cholesterol levels are associated with an increased risk of preeclampsia, a pregnancy complication that can lead to seizures, liver or kidney failure, and premature delivery. Women with high cholesterol before pregnancy are more likely to develop the condition, which affects thousands of women each year.
The matrilysin enzyme plays a key role in activating defensins to combat bacterial infections in the intestine. The researchers found that matrilysin is essential for regulating antimicrobial activity and protecting the epithelial lining from bacterial invasion.
Scientists have identified TNF-alpha as a major contributor to early liver injury from long-term alcohol consumption, paving the way for new treatments. The study used gene knockout technology and found that mice lacking TNF receptors fared better on measures of liver injury after alcohol exposure.
Researchers at Howard Hughes Medical Institute uncover the first human disease linked to a defect in the MECP2 gene silencer mechanism. The discovery provides new insights into nervous system development and may lead to new treatments for Rett Syndrome, a neurodevelopmental disorder causing mental regression in young girls.
Researchers have identified a new molecular marker for Alzheimer's disease, a normal cellular enzyme called casein kinase-1 (CK-1), which accumulates in nerve cells damaged by AD. CK-1 levels were found to be abnormally high in vacuoles within the hippocampus region of AD brains.
Researchers at Jefferson Medical College have uncovered a potential switch that helps control the manufacture of red blood cells and blood-clotting platelets. Activating 'death receptors' on immature red blood cells triggers caspases, which can halt excessive production by blocking cell growth and differentiation.
A study of infants with dense cataracts found that visual stimulation, not brain development, is responsible for the five-fold visual improvement within six months of birth. Babies' vision improved rapidly after cataract removal and contact lens fitting, with some developing 20/20 vision.
A team of researchers has identified a genetic link on mouse Chromosome 19 that controls inherited susceptibility to testicular cancer. The discovery uses a new genetic technique called chromosome substitution, which may lead to improved understanding and treatment options for the disease.